JQ-1 is a small-molecule bromodomain inhibitor that relieves liver fibrosis caused by Schistosoma japonicum infections by inhibiting JAK2/STAT3 signaling (Ding et al., 2021). Here, STAT3 is linked to Hepatic fibrosis.